Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
May 08, 2024 06:30 ET
|
Veru Inc.
--Phase 2b clinical study of enobosarm in combination with semaglutide (Wegovy®*) for high quality weight loss is actively enrolling-- --Company assembles esteemed high quality weight loss Scientific...
Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
May 08, 2024 06:30 ET
|
Beam Therapeutics
CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that...
Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder
May 08, 2024 06:30 ET
|
Compass Pathways
Study met primary safety endpoint; administration was well tolerated, with no serious adverse events observed Early and clinically meaningful improvement from baseline in mean CAPS-5 total score (29.5...
Taboola Q1 2024 Results Beat High End of Guidance; Reiterates 2024 Guidance and Expects Accelerating Growth Across All Key Metrics
May 08, 2024 06:15 ET
|
Taboola, Inc.
Q1 2024 and FY 2024 Key HighlightsQ1 Financials - beat high end of guidance across all key metrics Q1 2024 Revenues $414M, Gross profit $109M, ex-TAC Gross Profit $139M, Net loss $26M,...
Qifu Technology to Hold Annual General Meeting on June 27, 2024
May 08, 2024 06:01 ET
|
Qifu Technology, Inc.
SHANGHAI, China, May 08, 2024 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading Credit-Tech platform in China, today announced that...
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
May 08, 2024 06:00 ET
|
Regeneron Pharmaceuticals, Inc.
Preliminary data detailed in an ASGCT oral presentation include results for one of the youngest children in the world to receive a gene therapy for genetic deafness Ongoing Phase 1/2 CHORD trial is...
ACM Research Reports First Quarter 2024 Results
May 08, 2024 06:00 ET
|
ACM Research, Inc.
FREMONT, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging...
Enlight Renewable Energy Reports First Quarter 2024 Financial Results
May 08, 2024 06:00 ET
|
Enlight Renewable Energy Ltd.
All of the amounts disclosed in this press release are in U.S. dollars unless otherwise noted TEL AVIV, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- Enlight Renewable Energy Ltd. (NASDAQ: ENLT, TASE:...
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
May 08, 2024 06:00 ET
|
Fractyl Health, Inc.
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
Millicom (Tigo) Q1 2024 Earnings Release
May 08, 2024 06:00 ET
|
Millicom International Cellular S.A.
Millicom (Tigo) Q1 2024 Earnings Release Luxembourg, May 8, 2024 – Millicom is pleased to announce its first quarter 2024 results. Please find below links to the Q1 2024 Earnings Release and IAS 34...